Analyst firms · UBS · UNH

UBS UNH price target and rating history

UnitedHealth Group Incorporated (UNH) · Health Care

UBS rates UnitedHealth Group Incorporated (UNH) Buy with a $640 price target, as of its latest action on Oct 16, 2023. It has published 3 rating actions on UNH since December 2021, including 1 upgrade and 0 downgrades. Across 6 firms with a UNH price target in the last 12 months, the median target is $425.

Current rating
Buy
Price target
$640
Median target, all firms
$425
Actions on UNH
3

UBS price target on UNH

$640$546$45220222023202420252026
UBS price target on UNH, each point a stated target, December 2021 to October 2023.

Every UBS rating on UNH

How other firms rate UNH

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Erste GroupHoldAug 27, 2026
Robert W. BairdNeutral$453Jul 16, 2026
Leerink PartnersOutperform$462Jun 17, 2026
BofA SecuritiesBuy$450Jun 4, 2026
Argus ResearchBuy$400Apr 22, 2026
HSBCHold$300Apr 7, 2026
Raymond JamesOutperform$330Apr 1, 2026

Questions about UBS and UNH

What is UBS's price target for UNH?
UBS's latest stated price target for UnitedHealth Group Incorporated (UNH) is $640, from its action on Oct 16, 2023.
What is UBS's rating on UNH?
UBS rates UNH Buy, a bullish rating, as of Oct 16, 2023.
When did UBS last change its view on UNH?
On Oct 16, 2023, UBS upgrades to Buy from Neutral, price target $520 to $640.
How does UBS's UNH target compare with other analysts?
Across 6 firms with a UNH price target in the last 12 months, the median target is $425.

More UNH rating histories

All UBS ratingsUNH news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.